Dow to Acquire Three Leading Epoxy Manufacturers

Dow Epoxy, a global business unit of The Dow Chemical Company, announced today the signing of definitive agreements to acquire UPPC AG in Germany, and POLY-CARB Inc. and GNS Technologies in the United States. Each of these businesses is a leading epoxy systems formulator in its region. Dow expects to complete each acquisition within 30 to 45 days. Financial terms of the transactions were not disclosed.

These acquisitions are consistent with Dow’s strategy to invest in its downstream performance businesses. For Dow Epoxy, the acquisitions will accelerate the growth and geographic expansion of its new Dow Epoxy Systems business unit, which launched earlier this year. Dow Epoxy Systems offers solution-based epoxy systems to the industry.

“Dow Epoxy is a worldwide leading supplier of epoxies with considerable know-how, manufacturing and R&D capabilities, scale and global reach,” said Patrick Ho, business group president, Dow Epoxy & Specialty Chemicals. “Dow Epoxy Systems leverages our broad chemistry and applications know-how to provide innovative, solution-based systems to our customers. This supports Dow’s strategy to drive profitable growth by being a more customer- and market-driven company.”

Dow Epoxy Systems will focus on applications in civil engineering, specialty protective coatings, composites, wind energy, and other industries where Dow’s unique technology and systems solutions can offer performance enhancement and differentiation to customers.

“We are very excited about what the Epoxy Systems business of Dow Epoxy represents, which is a new engine of innovation and growth,” said Pepe Carnevale, global business director, Dow Epoxy Systems. “With this set of acquisitions, we considerably boost that engine with talented people, proven products, promising R&D pipelines, applications know-how and market channels. Combined with Dow Epoxy’s organic growth capabilities and epoxy expertise, we have a solid foundation upon which to build Dow Epoxy Systems.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.